Evaluation of stromal HGF immunoreactivity as a biomarker for melanoma response to RAF inhibitors
出版年份 2014 全文链接
标题
Evaluation of stromal HGF immunoreactivity as a biomarker for melanoma response to RAF inhibitors
作者
关键词
-
出版物
MODERN PATHOLOGY
Volume 27, Issue 9, Pages 1193-1202
出版商
Springer Nature
发表日期
2014-01-17
DOI
10.1038/modpathol.2013.226
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Ron Receptor Tyrosine Kinase Activation Confers Resistance to Tamoxifen in Breast Cancer Cell Lines
- (2015) Rebecca J. McClaine et al. NEOPLASIA
- BRAF Inhibition Is Associated with Enhanced Melanoma Antigen Expression and a More Favorable Tumor Microenvironment in Patients with Metastatic Melanoma
- (2013) D. T. Frederick et al. CLINICAL CANCER RESEARCH
- Impact of MET expression on outcome in BRAFV600E/Kadvanced melanoma
- (2013) Adrian M Jubb et al. HISTOPATHOLOGY
- Pharmacodynamic Effects and Mechanisms of Resistance to Vemurafenib in Patients With Metastatic Melanoma
- (2013) Kerstin Trunzer et al. JOURNAL OF CLINICAL ONCOLOGY
- Anti-PD-1 approaches—important steps forward in metastatic melanoma
- (2013) Mina Razzak Nature Reviews Clinical Oncology
- Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma
- (2013) Omid Hamid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Loss of 5-Hydroxymethylcytosine Is an Epigenetic Hallmark of Melanoma
- (2012) Christine Guo Lian et al. CELL
- Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial
- (2012) Gerald S Falchook et al. LANCET
- Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial
- (2012) Axel Hauschild et al. LANCET
- Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
- (2012) Ravid Straussman et al. NATURE
- Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors
- (2012) Timothy R. Wilson et al. NATURE
- Survival in BRAF V600–Mutant Advanced Melanoma Treated with Vemurafenib
- (2012) Jeffrey A. Sosman et al. NEW ENGLAND JOURNAL OF MEDICINE
- MAP kinase signaling and inhibition in melanoma
- (2012) R J Sullivan et al. ONCOGENE
- Melanoma Chemotherapy Leads to the Selection of ABCB5-Expressing Cells
- (2012) Marine Chartrain et al. PLoS One
- Revisiting the technical validation of tumour biomarker assays: how to open a Pandora's box
- (2011) Caterina Marchiò et al. BMC Medicine
- Hepatocyte Growth Factor Expression in EGFR Mutant Lung Cancer with Intrinsic and Acquired Resistance to Tyrosine Kinase Inhibitors in a Japanese Cohort
- (2011) Seiji Yano et al. Journal of Thoracic Oncology
- SOX2 contributes to melanoma cell invasion
- (2011) Sasha D Girouard et al. LABORATORY INVESTIGATION
- Unpublished results hide the decline effect
- (2011) Jonathan Schooler NATURE
- Bring on the biomarkers
- (2011) George Poste NATURE
- Improved outcomes for patients with metastatic melanoma
- (2011) Vernon K. Sondak et al. Nature Reviews Clinical Oncology
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Negative results are disappearing from most disciplines and countries
- (2011) Daniele Fanelli SCIENTOMETRICS
- Before You Analyze a Human Specimen, Think Quality, Variability, and Bias
- (2010) Mark David Lim et al. ANALYTICAL CHEMISTRY
- Acquired Resistance of Non-Small Cell Lung Cancer Cells to MET Kinase Inhibition Is Mediated by a Switch to Epidermal Growth Factor Receptor Dependency
- (2010) U. McDermott et al. CANCER RESEARCH
- Molecular mechanisms of acquired resistance to tyrosine kinase targeted therapy
- (2010) J Rafael Sierra et al. Molecular Cancer
- Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation
- (2010) Ramin Nazarian et al. NATURE
- Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
- (2010) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Do Pressures to Publish Increase Scientists' Bias? An Empirical Support from US States Data
- (2010) Daniele Fanelli PLoS One
- Hepatocyte Growth Factor Induces Gefitinib Resistance of Lung Adenocarcinoma with Epidermal Growth Factor Receptor-Activating Mutations
- (2008) S. Yano et al. CANCER RESEARCH
- Validation of Analytic Methods for Biomarkers Used in Drug Development
- (2008) C. H. Chau et al. CLINICAL CANCER RESEARCH
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Identification of cells initiating human melanomas
- (2008) Tobias Schatton et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now